Company intelligence / Profile preview

Chengdu Kanghua Biological Products Co., Ltd.

Chengdu*, Sichuan, Chinaen.kangh.com ↗
Ownership
Public · 300841
Employees
~672
Development stage
Commercial
01

Overview

Chengdu Kanghua has two main commercialized products—Group ACYW135 Meningococcal Polysaccharide Vaccine and Freeze-dried Human Rabies Vaccine (Human Diploid Cell)—with both products widely used in China and exported internationally. The company has a robust R&D pipeline with additional vaccine candidates under development. It holds over a hundred patents and has received multiple government awards for innovation[1][4][6].

Therapeutic areas
Infectious Diseases
Modalities
Polysaccharide vaccinesViral vaccines (e.g., rabies vaccine using human diploid cells)
Industry
Biotech
02

Drug pipeline

3 assets

rabies vaccine (human diploid cell, cultured by fixed bioreactor)

Preclinical

2 more assets in the full pipeline.

Request access →
03

Partnerships

HilleVax – exclusive license agreement for hexavalent VLP norovirus vaccine candidate outside China[6].International health organizations/government agencies for distribution partnerships mentioned generally but not named specifically[9].

Beyond the preview

Go deeper on Chengdu Kanghua Biological Products Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chengdu Kanghua Biological Products Co., Ltd..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call